Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Monjuvi
Pharma
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Incyte is preparing for four launches and four pivotal readouts in 2025, among many other pipeline developments.
Angus Liu
Jan 22, 2025 2:38pm
Incyte's Monjuvi proves its worth in follicular lymphoma
Nov 25, 2024 3:20pm
Incyte eyes upcoming launches as Jakafi's patent cliff nears
Oct 29, 2024 5:07pm
Incyte eyes label expansion for Monjuvi after phase 3 win
Aug 16, 2024 11:23am
Incyte picks up full Monjuvi rights from MorphoSys for $25M
Feb 6, 2024 9:59am
Novartis eyes MorphoSys buyout: Reuters
Feb 5, 2024 3:39pm
